Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Slovenia

Marie Skłodowska-Curie Action · Running

D1-Glia Astrocyte dopamine D1 receptor signaling in depression

Coordinator
Univerza V Ljubljani, Slovenia
Runs
1 April 2023 to 31 March 2025
Status
Running
EU funding
€171k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101090280

What the project is doing

In the project's own words, from its summary on CORDIS.

Major depressive disorders (MDD) represent a global challenge. Although many recent initiatives have resulted in new antipsychotic drugs, their efficacy is not optimal. One possible reason for this is that the prevailing paradigm for drug development is based on the neuron-centric view of how the central nervous system (CNS) copes with diseases. In the fellowship, I will study neuroglia, the nonneuronal cells responsible mainly for maintaining homeostasis in the CNS.

Failure in the function of these cells can set the course for neurological conditions, including psychiatric diseases and MDD. Thus, targeting neuroglia has recently been viewed as a new translational ground for drug development. The present proposal is therefore based on our understanding of the potential role of neuroglia in brain disease. One of the major neurotransmitters, dopamine, is known to play an important role in MDD.

I will examine the regulation of astrocytes, a major type of neuroglia, by dopamine. Based on the state of the art, I hypothesise that astrocytic dopamine D1 receptor signalling may be involved in the pathophysiology of MDD. Through innovative methodological approaches I will study the regulation of astrocytic D1 receptor signalling at the cellular level in an experimental model of MDD. Moreover, this project will explore D1 signalling in vivo to validate the results obtained on isolated cells.

The proposed research will provide a new framework that includes astrocytes and the mechanisms underlying the dopaminergic modulation in depression. This will afford novel cellular targets for treatment of MDD associated with dopamine D1 receptor signalling. In addition, a comprehensive two-way transfer of knowledge is envisioned to bring together competences and experiences necessary for the proposed research. The fellowship will facilitate my career development and enable me to get established in the field.

Topics

Who is involved

OrganisationCityCountryRole
Univerza V LjubljaniLjubljanaSloveniaCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI